PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA
B. Kahl,
J. Cohen,
R. Pillai,
V. Jayaprakash,
C. Wang,
M. Hahka-Kemppinen,
M. Kania,
P. Zinzani
Affiliations
B. Kahl
1 Washington University School of Medicine, St Loius
J. Cohen
2 Emory University School of Medicine, Atlanta
R. Pillai
3 HUTCHMED International Corporation, Florham Park, United States of America
V. Jayaprakash
3 HUTCHMED International Corporation, Florham Park, United States of America
C. Wang
3 HUTCHMED International Corporation, Florham Park, United States of America
M. Hahka-Kemppinen
3 HUTCHMED International Corporation, Florham Park, United States of America
M. Kania
3 HUTCHMED International Corporation, Florham Park, United States of America
P. Zinzani
4 University of Bologna Institute of Hematology, Bologna, Italy